L-Glutathione — Research Profile

Both approaches work. A 2015 RCT showed oral glutathione at 250-1000 mg/day increased blood levels by 30-35% ^[1]. However, liposomal or S-acetyl forms are recommended for better absorption ^[3]. NAC (N-acetyl cysteine) at 600-1200 mg/day boosts your body's own glutathione production and is more affordable ^[6]. For maximum effect, some practitioners combine both.

Multiple RCTs show oral glutathione at 500 mg/day can reduce melanin index and brighten skin tone over 4-12 weeks. It works by inhibiting tyrosinase and shifting melanin production from darker eumelanin to lighter pheomelanin. Results vary by individual, and effects are temporary — they reverse when supplementation stops.

Liposomal glutathione has the best oral bioavailability because the phospholipid coating protects it from degradation in the GI tract. S-Acetyl glutathione is another good option, offering stability and decent absorption. Standard reduced glutathione (GSH) is the cheapest but has lower bioavailability. IV glutathione has the highest bioavailability but requires clinical administration.

Oral reduced glutathione has the strongest human data: the 6-month RCT showed it raised glutathione in blood, erythrocytes, lymphocytes and buccal cells despite historical doubts about intact absorption. Sublingual glutathione has only been tested for vascular markers with mostly null results, and oxidized (GSSG) and reduced forms performed similarly for skin over 12 weeks. Intravenous glutathione is a clinical procedure, not a supplement form, so oral reduced GSH is the most evidence-supported choice for self-supplementation.

The best-supported effect is biochemical: oral supplementation raised body glutathione stores, lowered the oxidized-to-reduced glutathione ratio, and more than doubled natural-killer cell cytotoxicity in a 6-month RCT. For skin, 250 mg/day over 12 weeks significantly reduced wrinkles and tended to lower melanin and UV spots. Most evidence rests on small trials and surrogate markers rather than hard clinical outcomes, and vascular benefits from sublingual dosing appeared only in a small abnormal-baseline subgroup.

There is no official recommended intake, since glutathione is not an essential nutrient. Human oral trials have used 250-1,000 mg/day: 250 mg/day was enough to affect skin over 12 weeks, while 1,000 mg/day produced the largest increases in body glutathione stores (30-35% in blood cells) over 6 months. Higher doses gave bigger biochemical changes but have not been shown to translate into proportionally greater clinical benefit.

No study has compared morning versus evening or with-food versus fasted dosing, so an optimal time has not been identified. The trials that raised glutathione stores and affected skin simply used a fixed daily dose without specifying time of day. Pick a daily slot you can maintain, since the outcomes were driven by sustained daily intake over months, not by timing.

Oral glutathione was well tolerated in trials, with no serious adverse effects reported over 6 months at up to 1,000 mg/day or over 12 weeks at 250 mg/day. The main flagged concern is an allergic-type reaction, which can include rash, breathing problems or wheezing, and swelling of the face, lips, or throat. If any of those breathing or swelling symptoms occur, stop and seek medical care.

No specific drug interactions are well documented; the WebMD monograph reports no known interactions while noting that glutathione's interactions with medicines are not fully understood. This is an absence of evidence rather than proof of none, so the safe read is that interactions are simply under-studied. Anyone on chemotherapy or immune-modulating drugs should clear it with their prescriber given how little interaction data exists.

It is most reasonable for people specifically aiming to raise glutathione status or reduce oxidative-stress markers, where a 6-month RCT showed measurable increases, or for those targeting skin pigmentation and wrinkles, where 12-week trials showed modest effects (larger when paired with L-cystine). It is not established as necessary for healthy people whose bodies already synthesize glutathione. Pregnant or breastfeeding people should avoid it, since its effects in pregnancy are unknown and it passes into breast milk.

This depends on the endpoint, and most changes take weeks to months rather than days. In a 6-month oral RCT (250 or 1,000 mg/day), blood and tissue glutathione stores rose in a dose- and time-dependent way, with natural-killer cell cytotoxicity already more than doubled by 3 months. Skin studies of oral glutathione at 250 mg/day measured reductions in wrinkles and pigmentation only after 12 weeks, so expect a multi-week trial before judging any effect.

The longest controlled oral trials ran 6 months at up to 1,000 mg/day and 12 weeks at 250 mg/day, and neither reported serious adverse effects. Safety beyond roughly 6 months of continuous use has not been formally established in trials. The main documented risk is an allergic-type reaction, so use beyond these tested windows is not backed by direct data.

Glutathione is a tripeptide your body makes itself, and no tolerable upper intake level or toxic oral threshold has been defined. Oral doses up to 1,000 mg/day for 6 months were used without serious adverse effects, but higher or open-ended dosing has not been tested. The clearest risk from overdoing it is an allergic reaction (rash, wheezing, or facial swelling) rather than a classic overdose.

The best-tested pairing is with L-cystine: a 12-week trial in 124 women found 250 mg glutathione plus 500 mg L-cystine lightened skin and shrank dark spots significantly more than glutathione alone or placebo, reflecting cysteine's role as a rate-limiting precursor for glutathione synthesis. Whether stacking it with other antioxidants adds benefit for non-skin goals has not been established in controlled trials, so combinations should target a specific tested outcome rather than assume additive effects.

Choose a product whose label states the milligrams of reduced glutathione (GSH), the form shown in the 6-month RCT to raise body stores at 250-1,000 mg/day. There is no percentage-standardization to look for since glutathione is a defined tripeptide, not a plant extract, so the meaningful spec is the stated GSH dose and third-party purity testing. Be skeptical of proprietary blends that hide the actual glutathione amount.